Literature DB >> 28333181

Candida auris candidaemia in Indian ICUs: analysis of risk factors.

Shivaprakash M Rudramurthy1, Arunaloke Chakrabarti1, Raees A Paul1, Prashant Sood1, Harsimran Kaur1, Malini R Capoor2, Anupma J Kindo3, Rungmei S K Marak4, Anita Arora5, Raman Sardana6, Shukla Das7, Deepinder Chhina8, Atul Patel9, Immaculata Xess10, Bansidhar Tarai11, Pankaj Singh1, Anup Ghosh1.   

Abstract

Objectives: To identify the risk factors associated with Candida auris candidaemia, as this fungus now poses a global threat.
Methods: We performed a subgroup analysis of a previously reported study of 27 Indian ICUs. The clinical data of candidaemia cases due to C. auris and other Candida species were compared to determine significant risk factors associated with C. auris infection.
Results: Of the 1400 candidaemia cases reported earlier, 74 (5.3%) from 19 of 27 ICUs were due to C. auris . The duration of ICU stay prior to candidaemia diagnosis was significantly longer in patients with C. auris candidaemia (median 25, IQR 12-45 days) compared with the non- auris group (median 15, IQR 9-28, P  <   0.001). Based on logistic regression modelling, admission to north Indian ICUs [OR 2.1 (1.2-3.8); P  =   0.012], public-sector hospital [OR 2.2 (1.2-3.9); P  =   0.006], underlying respiratory illness [OR 2.1 (1.3-3.6); P  =   0.002], vascular surgery [OR 2.3 (1.00-5.36); P  =   0.048], prior antifungal exposure [OR 2.8 (1.6-4.8); P  <   0.001] and low APACHE II score [OR 0.8 (0.8-0.9); P  =   0.007] were significantly associated with C. auris candidaemia. The majority (45/51, 88.2%) of the isolates were clonal. A considerable number of isolates were resistant to fluconazole ( n  =   43, 58.1%), amphotericin B ( n  =   10, 13.5%) and caspofungin ( n  =   7, 9.5%). Conclusions: Although C. auris infection has been observed across India, the number of cases is higher in public-sector hospitals in the north of the country. Longer stay in ICU, underlying respiratory illness, vascular surgery, medical intervention and antifungal exposure are the major risk factors for acquiring C. auris infection even among patients showing lower levels of morbidity.
© The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28333181     DOI: 10.1093/jac/dkx034

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  75 in total

Review 1.  Candida auris: a Review of the Literature.

Authors:  Anna Jeffery-Smith; Surabhi K Taori; Silke Schelenz; Katie Jeffery; Elizabeth M Johnson; Andrew Borman; Rohini Manuel; Colin S Brown
Journal:  Clin Microbiol Rev       Date:  2017-11-15       Impact factor: 26.132

2.  Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome.

Authors:  Ziauddin Khan; Suhail Ahmad; Khalifa Benwan; Prashant Purohit; Inaam Al-Obaid; Ritu Bafna; Maha Emara; Eiman Mokaddas; Aneesa Ahmed Abdullah; Khaled Al-Obaid; Leena Joseph
Journal:  Infection       Date:  2018-06-14       Impact factor: 3.553

Review 3.  Candida auris: a fungus with identity crisis.

Authors:  Taissa Vila; Ahmed S Sultan; Daniel Montelongo-Jauregui; Mary Ann Jabra-Rizk
Journal:  Pathog Dis       Date:  2020-06-01       Impact factor: 3.166

4.  In Vitro Interactions of Echinocandins with Triazoles against Multidrug-Resistant Candida auris.

Authors:  Hamed Fakhim; Anuradha Chowdhary; Anupam Prakash; Afsane Vaezi; Eric Dannaoui; Jacques F Meis; Hamid Badali
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

5.  Candida auris.

Authors:  Ilan S Schwartz; Tanis C Dingle
Journal:  CMAJ       Date:  2019-08-06       Impact factor: 8.262

6.  Paired blood cultures increase the sensitivity for detecting pathogens in both inpatients and outpatients.

Authors:  Bansidhar Tarai; Dinesh Jain; Poonam Das; Sandeeep Budhiraja
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-01-11       Impact factor: 3.267

7.  Management of candiduria in hospitalized patients: a single-center study on the implementation of IDSA guidelines and factors affecting clinical decisions.

Authors:  Zhengxin He; Xiaosai Huo; Daxin Lei; Huihai Zhao; Keran Jia; Fukun Wang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2020-07-30       Impact factor: 3.267

8.  A Selective Medium for Isolation and Detection of Candida auris, an Emerging Pathogen.

Authors:  Sourav Das; Shreya Singh; Yamini Tawde; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy; Harsimran Kaur; Shamanth A Shankarnarayan; Anup Ghosh
Journal:  J Clin Microbiol       Date:  2021-01-21       Impact factor: 5.948

Review 9.  Candida auris: an Emerging Fungal Pathogen.

Authors:  Emily S Spivak; Kimberly E Hanson
Journal:  J Clin Microbiol       Date:  2018-01-24       Impact factor: 5.948

10.  First reported case of multidrug-resistant Candida auris in Canada.

Authors:  I S Schwartz; G W Hammond
Journal:  Can Commun Dis Rep       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.